+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Withdrawn

Phase 2
MALE
ID00000193

Neurobiology of Opioid Dependence 2

Led by Yale University · Updated on 2015-08-07

N/A

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.

CONDITIONS

Brief Title

Neurobiology of Opioid Dependence: 2 - 2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here